Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	57.6	67.45	121.97	67.27	37.6	19.52
Short-Term Investments	19.96	5	-	35.16	96.19	56.03
Cash & Short-Term Investments	77.57	72.45	121.97	102.43	133.79	75.55
Cash Growth	-3.84%	-40.60%	19.07%	-23.44%	77.09%	-32.92%
Accounts Receivable	42.44	39.2	30.83	17.46	6.88	4.69
Receivables	42.44	39.2	30.83	17.46	6.88	4.69
Inventory	42.98	38.84	24.74	18.12	8.35	2.18
Prepaid Expenses	7.36	5.78	9.29	4.59	3.2	5.07
Total Current Assets	170.34	156.26	186.82	142.6	152.21	87.48
Property, Plant & Equipment	28.7	29.18	9.51	6.63	6.71	7.85
Long-Term Investments	-	-	-	-	-	13.23
Goodwill	22.86	22.86	22.86	22.86	-	-
Other Intangible Assets	104.34	109.76	120.61	131.45	-	-
Long-Term Deferred Charges	-	-	-	-	-	0.4
Other Long-Term Assets	5.49	4.54	4.73	0.83	0.23	0.02
Total Assets	331.73	322.6	344.52	304.36	159.15	108.99
Accounts Payable	5.8	11.57	4.61	8.92	3.12	5.6
Accrued Expenses	46.77	45.66	44.09	51.17	21.07	19.49
Current Portion of Leases	5.31	3.5	1.58	-	-	-
Other Current Liabilities	17.61	34.47	23.35	18.95	4.02	2.24
Total Current Liabilities	75.49	95.19	73.62	79.04	28.21	27.34
Long-Term Debt	230.48	190.93	187.08	88.07	87.02	58.31
Long-Term Leases	34.02	34.76	9.4	-	-	-
Long-Term Deferred Tax Liabilities	3.32	2.27	3.52	4.94	-	-
Other Long-Term Liabilities	7.71	6.23	25.72	37.08	10.16	8.91
Total Liabilities	351.02	329.38	299.34	209.13	125.39	94.55
Common Stock	0.02	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	631.74	610.25	599.97	555.36	371.13	260.64
Retained Earnings	-651.01	-617.03	-554.77	-460.11	-337.39	-246.25
Comprehensive Income & Other	-0.03	-0.03	-0.02	-0.03	0.01	0.04
Total Common Equity	-19.29	-6.78	45.19	95.23	33.76	14.44
Shareholders' Equity	-19.29	-6.78	45.19	95.23	33.76	14.44
Total Liabilities & Equity	331.73	322.6	344.52	304.36	159.15	108.99
Total Debt	269.8	229.19	198.06	88.07	87.02	58.31
Net Cash (Debt)	-192.24	-156.74	-76.09	14.37	46.77	17.24
Net Cash Growth	-	-	-	-69.28%	171.21%	-78.64%
Net Cash Per Share	-1.36	-1.14	-0.56	0.18	1.10	0.66
Filing Date Shares Outstanding	149	140.45	137.29	135.52	59.76	37.57
Total Common Shares Outstanding	148.94	138.13	136.27	124.87	59.61	27.21
Working Capital	94.85	61.07	113.2	63.56	124.01	60.15
Book Value Per Share	-0.13	-0.05	0.33	0.76	0.57	0.53
Tangible Book Value	-146.49	-139.41	-98.28	-59.08	33.76	14.44
Tangible Book Value Per Share	-0.98	-1.01	-0.72	-0.47	0.57	0.53
Machinery	6.06	5.65	5.68	5.43	4.32	4.45
Leasehold Improvements	6.04	5.98	5.07	5.03	4.63	4.54

Source: S&P Capital IQ. Standard template. Financial Sources.